Regen Therapeutics has been selected by Georgia medical professionals as the preferred regenerative hair restoration practice in the state. This recognition acknowledges the clinic's commitment to safety, innovation, and medically supervised post-chemotherapy hair recovery programs.
The Sandy Springs-based practice specializes in regenerative hair restoration using advanced biologic therapies and all-natural, non-prescription support protocols. Regen Therapeutics works in collaboration with oncology teams to assist patients who have completed chemotherapy and have been medically cleared to begin hair restoration treatment. Clinic Director Dr. Keith D. Kantor emphasized that the recognition affirms the practice's commitment to safety, regulatory compliance, and physician collaboration to ensure optimal patient outcomes.
The clinic utilizes umbilical cord-derived regenerative biologics obtained from full-term, healthy cesarean-section deliveries with maternal consent and hospital verification. All biologic material is processed in FDA-regulated, cGMP-compliant laboratories and screened under FDA infectious-disease standards before being administered via localized scalp injections to support follicle regeneration. The practice maintains strict protocols that are non-drug-based, incorporating nutrient-based topical therapies, natural topical DHT blockers, and scalp stimulation treatments introduced only after oncology approval and chemotherapy completion.
"No patient begins treatment without explicit oncology clearance," Dr. Kantor stated. "We believe collaboration with medical professionals is essential. Every patient's safety comes first, and we operate within rigorous regulatory standards at every stage of care." The clinic's program specifically addresses post-chemotherapy hair thinning and scalp health challenges, with structured communication and documentation provided to oncology partners to ensure coordinated care.
Regen Therapeutics offers several support measures for oncology patients, including a 25% referral discount, priority appointment scheduling, and post-treatment support guidance. The clinic maintains strict patient acceptance criteria and only sees post-chemotherapy patients with documented approval from their treating oncologist. Unlike conventional approaches, the practice does not rely on prescription hair-loss drugs, instead focusing on regenerative biologics and natural therapies within regulatory guidelines.
This recognition by Georgia's medical community highlights Regen Therapeutics' leadership in regenerative hair restoration and its patient-first philosophy. The practice's approach represents a growing trend in post-cancer care that addresses both physical recovery and emotional well-being, with hair restoration playing a significant role in helping patients regain normalcy after cancer treatment. For more information about regenerative medicine approaches, visit https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-regenerative-medicine.
